BOT.AX
Price:
$0.455
Market Cap:
$827.02M
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that ...[Read more]
Industry
Biotechnology
IPO Date
1988-01-31
Stock Exchange
ASX
Ticker
BOT.AX
According to Botanix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 22.21. This represents a change of 110.48% compared to the average of 10.55 of the last 4 quarters.
The mean historical Current Ratio of Botanix Pharmaceuticals Limited over the last ten years is 11.79. The current 22.21 Current Ratio has changed 18.74% with respect to the historical average. Over the past ten years (40 quarters), BOT.AX's Current Ratio was at its highest in in the June 2024 quarter at 22.21. The Current Ratio was at its lowest in in the September 2010 quarter at 0.
Average
11.79
Median
12.49
Minimum
1.13
Maximum
22.21
Discovering the peaks and valleys of Botanix Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.49%
Maximum Annual Current Ratio = 22.21
Minimum Annual Increase = -91.43%
Minimum Annual Current Ratio = 1.13
Year | Current Ratio | Change |
---|---|---|
2024 | 22.21 | 199.54% |
2023 | 7.42 | 315.63% |
2022 | 1.78 | -91.43% |
2021 | 20.82 | 15.80% |
2020 | 17.98 | 1.49% |
2019 | 1.13 | -90.89% |
2018 | 12.42 | -1.03% |
2017 | 12.55 | 75.16% |
2016 | 7.17 | -50.30% |
2015 | 14.42 | 74.98% |
The current Current Ratio of Botanix Pharmaceuticals Limited (BOT.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
10.47
5-year avg
14.04
10-year avg
11.79
Botanix Pharmaceuticals Limited’s Current Ratio is greater than MGC Pharmaceuticals Limited (0.76), greater than Zelira Therapeutics Limited (0.60), greater than Creso Pharma Limited (0.76), greater than Cann Group Limited (0.21), greater than Althea Group Holdings Limited (0.64),
Company | Current Ratio | Market cap |
---|---|---|
0.76 | $18.42M | |
0.60 | $7.38M | |
0.76 | $23.11M | |
0.21 | $20.36M | |
0.64 | $13.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Botanix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Botanix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Botanix Pharmaceuticals Limited's Current Ratio?
How is the Current Ratio calculated for Botanix Pharmaceuticals Limited (BOT.AX)?
What is the highest Current Ratio for Botanix Pharmaceuticals Limited (BOT.AX)?
What is the 3-year average Current Ratio for Botanix Pharmaceuticals Limited (BOT.AX)?
What is the 5-year average Current Ratio for Botanix Pharmaceuticals Limited (BOT.AX)?
How does the current Current Ratio for Botanix Pharmaceuticals Limited (BOT.AX) compare to its historical average?